SCHEMBL16997289

SCHEMBL16997289

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc2c(c1)c1c(-c3cc(-c4nc(-c5ccc(C(C)(C)C)cc5)nc(-c5ccc(C)c(-c6cccc7c6c6cc(-n8c9ccc(C)cc9c9cc(C)ccc98)ccc6n7-c6ccccc6)c5)n4)ccc3C)cccc1n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NR1H4 Q96RI1 3/20 0.36
PDE10A Q9Y233 1/20 0.33
TP53 P04637 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PPARG P37231 3/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
MEN1 O00255 2/20 0.31
RAB9A P51151 2/20 0.31
KMT2A Q03164 2/20 0.31
OPRD1 P41143 2/20 0.31
OPRM1 P35372 1/20 0.31
PPARA Q07869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16997279 0.94 ALDH1A1 (0.34) MAPTALDH1A1MAPK1NPSR1PDE10A
SCHEMBL16997270 0.94 RXFP1 (0.35) MAPTALDH1A1PDE10ATP53SMN1; SMN2
SCHEMBL16997288 0.91 TP53 (0.34) ALDH1A1NPSR1TP53PPARGRXFP1
SCHEMBL16997287 0.89 ALDH1A1 (0.37) MAPTALDH1A1MAPK1NPSR1PDE10A
SCHEMBL16997286 0.89 ALDH1A1 (0.37) MAPTALDH1A1MAPK1NPSR1PDE10A
SCHEMBL16997278 0.87 AKR1C4 (0.36) MAPTALDH1A1MAPK1NPSR1TP53
SCHEMBL16997266 0.87 L3MBTL1 (0.38) ALDH1A1PDE10ARXRARXFP1MEN1
SCHEMBL16997277 0.84 RXFP1 (0.35) MAPTALDH1A1PDE10ATP53RXFP1
SCHEMBL16997282 0.83 KDM4E (0.36) PDE10ARXFP1MEN1RAB9AKMT2A
SCHEMBL16997275 0.83 RXRA (0.34) RXRARXFP1MEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9911925-B2 Carbazole-based compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-03-06 US disclosed
US-9911925-B2 Carbazole-based compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-03-06 US disclosed
US-20150228908-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-08-13 US disclosed
US-20150228908-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2015-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150228908-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1B1, CYP1A1, CRY1 MAPT 1926/4885ALDH1A1 45/4885MAPK1 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.